[A13-16] Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 01.07.2013
Project no.:
A13-16
Commission:
Commission awarded on 28.03.2013 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Digestion, metabolism and hormones
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Accompanying information| Project no. | Title | Status |
|---|---|---|
| A14-46 | Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
| A13-30 | Addendum to Commission A13-16 (vildagliptin) | Commission completed |
Federal Joint Committee (G-BA)
2013-10-01 A G-BA decision was published.